STOCK TITAN

Bausch Health Announces Participation In Upcoming Investor Conferences

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Bausch Health Companies (NYSE/TSX: BHC) announced its participation in two significant investor conferences. The leadership team, including Joseph C. Papa and Sam Eldessouky, will present at the Credit Suisse 30th Annual Healthcare Conference on Nov. 10, 2021, at 10:30 a.m. ET, and at the Evercore ISI HealthCONx Conference on Dec. 1, 2021, at 1:00 p.m. ET. A live webcast will be available on the company’s Investor Relations page.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – BHC

-0.66%
-0.66% Session move

In the trading session that priced this news, BHC declined 0.66%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LAVAL, QC, Nov. 4, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in upcoming investor conferences.

Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, executive vice president and chief financial officer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Credit Suisse 30th Annual Healthcare Conference on Nov. 10, 2021 at 10:30 a.m. ET and at the Evercore ISI HealthCONx Conference on Dec. 1, 2021 at 1:00 p.m.ET.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2021.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

Investor Contact:               

Media Contact:

Arthur Shannon                    

Lainie Keller

arthur.shannon@bauschhealth.com   

lainie.keller@bauschhealth.com

(514) 856-3855                                   

(908) 927-1198

(877) 281-6642 (toll free)  


 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301416074.html

SOURCE Bausch Health Companies Inc.

FAQ

What conferences will Bausch Health participate in during November 2021?

Bausch Health will participate in the Credit Suisse 30th Annual Healthcare Conference on November 10, 2021.

When is Bausch Health presenting at the Evercore ISI HealthCONx Conference?

Bausch Health is scheduled to present at the Evercore ISI HealthCONx Conference on December 1, 2021, at 1:00 p.m. ET.

Who from Bausch Health will be speaking at the investor conferences?

Joseph C. Papa, Sam Eldessouky, and Arthur J. Shannon will represent Bausch Health at the conferences.

Where can I watch the Bausch Health investor presentations?

The presentations will be available via a live webcast on Bausch Health's Investor Relations page.

What is the stock symbol for Bausch Health?

The stock symbol for Bausch Health is BHC.